# Post-approval Study of Percutaneous Left Atrial Appendage Closure ( FLAAC-2 )

> **NCT03434015** · — · COMPLETED · sponsor: **French Cardiology Society** · enrollment: 1051 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03434015
- **Lead sponsor:** French Cardiology Society
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-09
- **Primary completion:** 2020-02-15
- **Final completion:** 2021-10-07
- **Target enrollment:** 1051 (ACTUAL)
- **Last updated:** 2022-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03434015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03434015, "Post-approval Study of Percutaneous Left Atrial Appendage Closure ( FLAAC-2 )". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03434015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
